Jung Suk Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jung Suk Choi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jiyun Lee
Department of Thoracic and Cardiovascular Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2 shared publications - Mi Hyoung Moon
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea
2 shared publications - Seok Whan Moon
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
2 shared publications - Youngkyu Moon
Department of Thoracic & Cardiovascular Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2 shared publications - Hwan Wook Kim
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Republic of Korea.
1 shared publication - Jae Kil Park
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 5 June 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (3) , 93-103
Impact of Sarcopenia on Early Postoperative Complications in Early-Stage Non–Small-Cell Lung Cancer
Jiyun Lee, M.D., Seok Whan Moon, M.D., Ph.D., Jung Suk Choi, M.D., Kwanyong Hyun, M.D., Young Kyu Moon, M.D., Ph.D., Mi Hyoung Moon, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2020;53:93-103. https://doi.org/10.5090/kjtcs.2020.53.3.93
- 5 June 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (3) , 93-103
Open AccessImpact of Sarcopenia on Early Postoperative Complications in Early-Stage Non–Small-Cell Lung Cancer
Jiyun Lee, M.D., Seok Whan Moon, M.D., Ph.D., Jung Suk Choi, M.D., Kwanyong Hyun, M.D., Young Kyu Moon, M.D., Ph.D., Mi Hyoung Moon, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2020;53:93-103. https://doi.org/10.5090/kjtcs.2020.53.3.93
- Open Access
- 5 June 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (3) , 104-113
Nodal Outcomes of Uniportal versus Multiportal Video-Assisted Thoracoscopic Surgery for Clinical Stage I Lung Cancer
Accurate intraoperative assessment of mediastinal lymph nodes is a critical aspect of lung cancer surgery. The efficacy and potential for upstaging implicit in these dissections must therefore be revisited in the current era of uniportal video-assisted thoracoscopic surgery (VATS). A retrospective study was conducted in which 544 patients with stage I (T1abc-T2a, N0, M0) primary lung cancer were analyzed. To assess risk factors for nodal upstaging and to limit any imbalance imposed by surgical choices, we constructed an inverse probability of treatment-weighted (IPTW) logistic regression model (in addition to non-weighted logistic models). We also evaluated risk factors for early locoregional recurrence using IPTW logistic regression analysis. In the comparison of uniportal and multiportal VATS, the resected lymph node count (14.03±8.02 vs. 14.41±7.41, respectively; p=0.48) and rate of nodal upstaging (6.5% vs. 8.7%, respectively; p=0.51) appeared similar. Predictors of nodal upstaging included tumor size (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.12-2.70), carcinoembryonic antigen level (OR, 1.11; 95% CI, 1.04-1.18), and histologically confirmed pleural invasion (OR, 3.97; 95% CI, 1.89-8.34). The risk factors for locoregional recurrence within 1 year were found to be number of resected N2 nodes, age, and nodal upstaging. Uniportal and multiportal VATS appear similar with regard to accuracy and thoroughness, showing no significant difference in the extent of nodal dissection.
- 5 June 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 53 (3) , 104-113
Open AccessNodal Outcomes of Uniportal versus Multiportal Video-Assisted Thoracoscopic Surgery for Clinical Stage I Lung Cancer
Accurate intraoperative assessment of mediastinal lymph nodes is a critical aspect of lung cancer surgery. The efficacy and potential for upstaging implicit in these dissections must therefore be revisited in the current era of uniportal video-assisted thoracoscopic surgery (VATS). A retrospective study was conducted in which 544 patients with stage I (T1abc-T2a, N0, M0) primary lung cancer were analyzed. To assess risk factors for nodal upstaging and to limit any imbalance imposed by surgical choices, we constructed an inverse probability of treatment-weighted (IPTW) logistic regression model (in addition to non-weighted logistic models). We also evaluated risk factors for early locoregional recurrence using IPTW logistic regression analysis. In the comparison of uniportal and multiportal VATS, the resected lymph node count (14.03±8.02 vs. 14.41±7.41, respectively; p=0.48) and rate of nodal upstaging (6.5% vs. 8.7%, respectively; p=0.51) appeared similar. Predictors of nodal upstaging included tumor size (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.12-2.70), carcinoembryonic antigen level (OR, 1.11; 95% CI, 1.04-1.18), and histologically confirmed pleural invasion (OR, 3.97; 95% CI, 1.89-8.34). The risk factors for locoregional recurrence within 1 year were found to be number of resected N2 nodes, age, and nodal upstaging. Uniportal and multiportal VATS appear similar with regard to accuracy and thoroughness, showing no significant difference in the extent of nodal dissection.
- Open Access
- 5 December 2019
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 52 (6) , 416-419
Thromboexclusion Treatment for Recurrent Aortic Aneurysm: Still an Option in Select Cases
Jung Suk Choi, M.D., Hwan Wook Kim, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2019;52:416-9. https://doi.org/10.5090/kjtcs.2019.52.6.416
- 5 December 2019
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 52 (6) , 416-419
Open AccessThromboexclusion Treatment for Recurrent Aortic Aneurysm: Still an Option in Select Cases
Jung Suk Choi, M.D., Hwan Wook Kim, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2019;52:416-9. https://doi.org/10.5090/kjtcs.2019.52.6.416